Neurodegenerative shielding by curcumin and its derivatives on brain lesions induced by 6-OHDA model of Parkinson's disease in albino wistar rats

Cardiovascular Psychiatry and Neurology

Volumn , Issue , 2012, Pages

  Agrawal, Shyam Sunder ^a   Gullaiya, Sumeet ^a   Dubey, Vishal ^a   Singh, Varun ^a   Kumar, Ashok ^a   Nagar, Ashish ^a   Tiwari, Poonam ^b  

^a DELHI INSTITUTE OF PHARMACEUTICAL SCIENCES AND RESEARCH   (India)

^b Innovative College of Pharmacy   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CURCUMIN; DEMETHOXYCURCUMIN; DIDEMETHOXYCURCUMIN; DOPAMINE; DOPAMINE 2 RECEPTOR; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BINDING ASSAY; BRAIN DAMAGE; CELL LOSS; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; DRUG EFFICACY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOHISTOCHEMISTRY; MALE; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; RECEPTOR BINDING;

EID: 84866262431     PISSN: 20900163     EISSN: 20900171     Source Type: Journal    
DOI: 10.1155/2012/942981     Document Type: Article

References (24)

1. Herdman R. C., Potter B. B., Neural Grafting: Repairing the Brain and Spinal Cord 1990 Washington, DC, USA Government Printing Office. U.S. Congress, Office of Technology Assessment
2. Yuan H., Liang L. W., Chen Z. J., Ji H. R., Wang M. K., Zhang H. Y., Li C., Xu J. Y., R-apomorphine protects against 6-hydroxydopamine-induced nigrostriatal damage in rat. Neuroscience Bulletin 2006 22 6 331 338 2-s2.0-33947162001 (Pubitemid 46406277)
3. Schober A., Classic toxin-induced animal models of Parkinson's disease: 6-OHDA and MPTP. Cell and Tissue Research 2004 318 1 215 224 2-s2.0-5544229693 10.1007/s00441-004-0938-y (Pubitemid 39366054)
4. Papa S. M., Chase T. N., Levodopa-induced dyskinesias improved by a glutamate antagonist in Parkinsonian monkeys. Annals of Neurology 1996 39 5 574 578 2-s2.0-0029665122
5. Chesselet M.-F., Richter F., Modelling of Parkinson's disease in mice. The Lancet Neurology 2011 10 12 1108 1118 2-s2.0-81255210997 10.1016/S1474-4422(11)70227-7
6. Cole G. M., Teter B., Frautschy S. A., Neuroprotective effects of curcumin. Advances in Experimental Medicine and Biology 2007 595 197 212 2-s2.0-34347216379 10.1007/978-0-387-46401-5-8
7. Hatcher H., Planalp R., Cho J., Torti F. M., Torti S. V., Curcumin: from ancient medicine to current clinical trials. Cellular and Molecular Life Sciences 2008 65 11 1631 1652 2-s2.0-44749093175 10.1007/s00018-008-7452-4
8. Aggarwal B. B., Sung B., Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets. Trends in Pharmacological Sciences 2009 30 2 85 94 2-s2.0-59349120231 10.1016/j.tips.2008. 11.002
9. Tonnesen H. H., Studies on curcumin and curcuminoids. XV. Catalytic effect of demethoxy- and bisdemethoxycurcumin on the peroxidation of linoleic acid by 15-lipoxygenase. International Journal of Pharmaceutics 1989 51 2 179 181 2-s2.0-0024500722 (Pubitemid 19096518)
10. Inano H., Onoda M., Inafuku N., Kubota M., Kamada Y., Osawa T., Kobayashi H., Wakabayashi K., Potent preventive action of curcumin on radiation-induced initiation of mammary tumorigenesis in rats. Carcinogenesis 2000 21 10 1835 1841 2-s2.0-0033791216
11. 2 dopamine receptor-deficient mice is determined by gene dosage, genetic background, and developmental adaptations. Journal of Neuroscience 1998 18 9 3470 3479 2-s2.0-20244389989 (Pubitemid 28186038)
12. Boissier J. R., Simon P., Action of caffeine on the spontaneous motility of the mouse. Archives Internationales de Pharmacodynamie et de Therapie 1965 158 1 212 221 2-s2.0-0013811904
13. Pandey D. K., Mahesh R., kumar A. A., Rao V. S., Arjun M., Rajkumar R., A novel 5-HT2A receptor antagonist exhibits antidepressant-like effects in a battery of rodent behavioural assays: approaching early-onset antidepressants. Pharmacology Biochemistry and Behavior 2010 94 3 363 373 2-s2.0-72149119722 10.1016/j.pbb.2009.09.018
14. Paxinos G., Watson C., The Rat Brain Stereotaxic Coordinates 1981 Sydney, Australia Academic Press
15. Agrawal A. K., Squibb R. E., Bondy S. C., The effects of acrylamide treatment upon the dopamine receptor. Toxicology and Applied Pharmacology 1981 58 1 89 99 2-s2.0-0019411690 (Pubitemid 11102611)
16. Haikala H., Use of a novel type of rotating disc electrode and a flow cell with laminar flow pattern for the electrochemical detection of biogenic monoamines and their metabolites after Sephadex gel chromatographic purification and high-performance liquid chromatographic isolation from rat brain. Journal of Neurochemistry 1987 49 4 1033 1041 2-s2.0-0023230009 (Pubitemid 17139466)
17. Kilpatrick I. C., Jones M. W., Phillipson O. T., A semiautomated analysis method for catecholamines, indoleamines, and some prominent metabolites in microdissected regions of the nervous system: an isocratic HPLC technique employing coulometric detection and minimal sample preparation. Journal of Neurochemistry 1986 46 6 1865 1876 2-s2.0-0022644209 (Pubitemid 16095494)
18. Mishra S., Palanivelu K., The effect of curcumin (turmeric) on Alzheimer's disease: an overview. Annals of Indian Academy of Neurology 2008 11 1 13 19 2-s2.0-42249112650 (Pubitemid 351550812)
19. Shingo T., Date I., Yoshida H., Ohmoto T., Neuroprotective and restorative effects of intrastriatal grafting of encapsulated GDNF-producing cells in a rat model of Parkinson's disease. Journal of Neuroscience Research 2002 69 6 946 954 2-s2.0-0037106156 10.1002/jnr.10375 (Pubitemid 34984712)
20. Zecca L., Zucca F. A., Wilms H., Sulzer D., Neuromelanin of the substantia nigra: a neuronal black hole with protective and toxic characteristics. Trends in Neurosciences 2003 26 11 578 580 2-s2.0-0242285663 10.1016/j.tins.2003.08.009 (Pubitemid 37338363)
21. Malkus K. A., Tsika E., Ischiropoulos H., Oxidative modifications, mitochondrial dysfunction, and impaired protein degradation in Parkinson's disease: how neurons are lost in the Bermuda triangle. Molecular Neurodegeneration 2009 4 1, article 24 2-s2.0-68149156531 10.1186/1750-1326-4-24
22. Kelley B. J., Knopman D. S., Alternative medicine and Alzheimer disease. Neurologist 2008 14 5 299 306 2-s2.0-53549104731 10.1097/NRL.0b013e318172cf4d
23. Yang F., Lim G. P., Begum A. N., Ubeda O. J., Simmons M. R., Ambegaokar S. S., Chen P., Kayed R., Glabe C. G., Frautschy S. A., Cole G. M., Curcumin inhibits formation of amyloid β oligomers and fibrils, binds plaques, and reduces amyloid in vivo. Journal of Biological Chemistry 2005 280 7 5892 5901 2-s2.0-20044370990 10.1074/jbc.M404751200 (Pubitemid 40280072)
24. Yodkeeree S., Chaiwangyen W., Garbisa S., Limtrakul P., Curcumin, demethoxycurcumin and bisdemethoxycurcumin differentially inhibit cancer cell invasion through the down-regulation of MMPs and uPA. Journal of Nutritional Biochemistry 2009 20 2 87 95 2-s2.0-58149119999 10.1016/j.jnutbio.2007.12.003